Abstract
The effect of recombinant human tumor necrosis factor-alpha (rhTNF-α)on rodent hematopoietic precursors and hepatocytes was evaluated. rhTNF-α appears to have minimal toxic effects on isolated hepatocytes and on granulocytemacrophage colony-forming units (CFU-GM) in vitro. It does, however, show a dose- and schedule-dependent inhibition of pluripotent bone marrow stem cells in mice. This was most evident with prolonged continuous infusion schedules. In contrast, single daily injections of rhTNF-α did not depress bone marrow or peripheral blood counts, although slight elevations in hepatic enzyme levels were apparent. These studies suggest that continuous infusions of rhTNF-α in man may produce enhanced bone marrow suppression over equivalent bolus doses.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 159-167 |
| Number of pages | 9 |
| Journal | Cancer Drug Delivery |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1987 |
ASJC Scopus subject areas
- Pharmacology
- Cancer Research